Results 11 to 20 of about 354,830 (305)

Identification of Anti-HIV/Migraine Drugs as Potential Inhibitors of SARS-Cov2 Main Protease Using in Silico Assessments

open access: yesThe Journal of Qazvin University of Medical Sciences, 2022
Background The acute respiratory syndrome named “COVID-19” is caused by a novel coronavirus called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Hanifeh Shariatifar   +3 more
doaj   +1 more source

Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi Hastanesi Kan Donörlerinde HCV, HIV ve HBV Seroprevalansı

open access: yesSakarya Tıp Dergisi, 2017
Amaç: Çoğu viral olmak üzere çeşitli enfeksiyon etkenlerinin alıcıya bulaşması kan transfüzyonlarının en sık karşılaşılan komplikasyonudur. Bu etkenler asemptomatik, akut, kronik ve latent enfeksiyonlara neden olabilirler.
Uğur Tüzüner   +3 more
doaj   +1 more source

Novel Cell type-specific aptamer-siRNA delivery system for HIV-1 therapy [PDF]

open access: yes, 2007
The successful use of small interfering RNAs (siRNAs) for therapeutic purposes requires safe and efficient delivery to specific cells and tissues. Here we demonstrate cell type-specific delivery of anti-HIV siRNAs via fusion to an anti-gp120 aptamer. The
Haitang Li   +4 more
core   +2 more sources

Diagnostic Efficacy of Photostimulated Chemiluminescence Assay for Detecting Anti-HIV Antibodies: A Retrospective Study

open access: yesPolish Journal of Microbiology, 2023
The transmission of human immunodeficiency virus (HIV) through blood poses a slightly increased risk. As a result, patients requiring blood transfusions should be screened for HIV antibodies.
Han Jianxiang   +3 more
doaj   +1 more source

Predicting the risk of pulmonary tuberculosis based on the neutrophil-to-lymphocyte ratio at TB screening in HIV-infected individuals

open access: yesBMC Infectious Diseases, 2019
Background The neutrophil to lymphocyte ratio (NL ratio) has been reported to be a predictive biomarker of tuberculosis (TB). We assessed the association between the NL ratio and the incidence of active TB cases within 1 year after TB screening among HIV-
Reiko Miyahara   +11 more
doaj   +1 more source

Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties

open access: yesToxins, 2020
Ribosome-inactivating proteins (RIPs) are N-glycosidases, which depurinate a specific adenine residue in the conserved α-sarcin/ricin loop (α-SRL) of rRNA.
Jia-Qi Lu   +3 more
doaj   +1 more source

Development of Mucoadhesive Gel Microbicide to Target Mucosal HIV Reservoirs [PDF]

open access: yes, 2014
The wide use of microbicide is mainly depends on its effectiveness, less frequent application, ready availability and most importantly cost. The aim of this work was to develop affordable microbicide mucoadhesive gel formulation of synthetic anti HIV ...
Shegokar, Ranjita, Singh, Kamalinder K
core   +1 more source

EFFECT OF FREE ALKALOID AND NON-FREE ALKALOID ETHANOL 70% EXTRACT OF JUSTICIA GENDARUSSA BURM F. LEAVES AGAINST REVERSE TRANSCRIPTASE HIV ENZYME IN VITRO AND CHEMICAL COMPOUND ANALYSIS

open access: yesIndonesian Journal of Tropical and Infectious Disease, 2016
HIV-AIDS is a global problem and the deadliest disease in the world. One of HIV and AIDS prevention strategy can be done with traditional medicine research program from natural resource that has anti-HIV AIDS activity.
Bambang Prajogo   +2 more
doaj   +1 more source

Method development and validation for multi-component analysis of lamivudine & tenofovir disoproxil fumarate in bulk drug by UV-visible spectrophotometer & RP-HPLC

open access: yesJournal of Applied Pharmaceutical Research, 2020
A novel, simple, precise and accurate method developed for the estimation of Lamivudine and tenofovir disoproxil fumarate (TDF) in bulk drug form has been established. Lamivudine and tenofovir are well known drugs and used in treatment of HIV- Ⅰ.
Shweta Sharma   +3 more
doaj   +1 more source

New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinities [PDF]

open access: yes, 2015
CXCR4 is a target of growing interest for the development of new therapeutic drugs and imaging agents as its role in multiple disease states has been demonstrated.
Archibald, Stephen J.   +14 more
core   +2 more sources

Home - About - Disclaimer - Privacy